These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31939847)

  • 1. Heart Rate Control during Experimental Sepsis in Mice: Comparison of Ivabradine and β-Blockers.
    Bedet A; Voiriot G; Ternacle J; Marcos E; Adnot S; Derumeaux G; Mekontso Dessap A
    Anesthesiology; 2020 Feb; 132(2):321-329. PubMed ID: 31939847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation of ivabradine in cardiogenic shock.
    Chiu MH; Howlett JG; Sharma NC
    ESC Heart Fail; 2019 Oct; 6(5):1088-1091. PubMed ID: 31332966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-life indications to ivabradine treatment for heart rate optimization in patients with chronic systolic heart failure.
    Tondi L; Fragasso G; Spoladore R; Pinto G; Gemma M; Slavich M; Godino C; Salerno A; Montanaro C; Margonato A
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):351-356. PubMed ID: 29762337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart rate reduction improves biventricular function and interactions in experimental pulmonary hypertension.
    Gomez O; Okumura K; Honjo O; Sun M; Ishii R; Bijnens B; Friedberg MK
    Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H542-H551. PubMed ID: 29146614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ivabradine on heart rate and left ventricular function in healthy cats and cats with hypertrophic cardiomyopathy.
    Riesen SC; Schober KE; Smith DN; Otoni CC; Li X; Bonagura JD
    Am J Vet Res; 2012 Feb; 73(2):202-12. PubMed ID: 22280379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
    Swedberg K; Komajda M; Böhm M; Borer J; Robertson M; Tavazzi L; Ford I;
    J Am Coll Cardiol; 2012 May; 59(22):1938-45. PubMed ID: 22617188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial.
    Nguyen LS; Squara P; Amour J; Carbognani D; Bouabdallah K; Thierry S; Apert-Verneuil C; Moyne A; Cholley B
    Crit Care; 2018 Aug; 22(1):193. PubMed ID: 30115103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing Elevated Heart Rates in Patients with Multiple Organ Dysfunction Syndrome with The If (Funny Channel Current) Inhibitor Ivabradine.
    Nuding S; Schröder J; Presek P; Wienke A; Müller-Werdan U; Ebelt H; Werdan K
    Shock; 2018 Apr; 49(4):402-411. PubMed ID: 28930912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart rate reduction by inhibition of If or by beta-blockade has different effects on postsystolic wall thickening.
    Lucats L; Ghaleh B; Colin P; Monnet X; Bizé A; Berdeaux A
    Br J Pharmacol; 2007 Feb; 150(3):335-41. PubMed ID: 17179940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. If Channel Inhibition With Ivabradine Does Not Improve Cardiac and Vascular Function in Experimental Septic Shock.
    Wei C; Al Kattani N; Louis H; Albuisson E; Levy B; Kimmoun A
    Shock; 2016 Sep; 46(3):297-303. PubMed ID: 26909707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy).
    Tendera M; Talajic M; Robertson M; Tardif JC; Ferrari R; Ford I; Steg PG; Fox K;
    Am J Cardiol; 2011 Mar; 107(6):805-11. PubMed ID: 21247517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of heart rate reduction and beta-blockade on left ventricular relaxation during exercise.
    Colin P; Ghaleh B; Hittinger L; Monnet X; Slama M; Giudicelli JF; Berdeaux A
    Am J Physiol Heart Circ Physiol; 2002 Feb; 282(2):H672-9. PubMed ID: 11788417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.
    Tardif JC; Ponikowski P; Kahan T;
    Eur Heart J; 2009 Mar; 30(5):540-8. PubMed ID: 19136486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivabradine in Heart Failure: The Representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a Broad Population of Patients With Chronic Heart Failure.
    Das D; Savarese G; Dahlström U; Fu M; Howlett J; Ezekowitz JA; Lund LH
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28903983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart Rate Reduction With Ivabradine Protects Against Left Ventricular Remodeling by Attenuating Infarct Expansion and Preserving Remote-Zone Contractile Function and Synchrony in a Mouse Model of Reperfused Myocardial Infarction.
    O'Connor DM; Smith RS; Piras BA; Beyers RJ; Lin D; Hossack JA; French BA
    J Am Heart Assoc; 2016 Apr; 5(4):. PubMed ID: 27107133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of ivabradine and atenolol in patients with moderate mitral stenosis in sinus rhythm.
    Rajesh GN; Sajeer K; Sajeev CG; Bastian C; Vinayakumar D; Muneer K; Haridasan V; Mathew D; George B; Krishnan MN
    Indian Heart J; 2016; 68(3):311-5. PubMed ID: 27316483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of Ivabradine Therapy in Up-Titrating Beta-Blocker Dose in Patients with Systolic Dysfunction.
    Imamura T; Onoda H; Uchida K; Kinugawa K
    Int Heart J; 2021 Nov; 62(6):1305-1309. PubMed ID: 34744149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Blockers and ivabradine differentially affect cardiopulmonary function and left ventricular filling index.
    Fischer-Rasokat U; Honold J; Lochmann D; Wolter S; Liebetrau C; Fichtlscherer S; Möllmann H; Spyridopoulos I; Hamm CW
    Clin Res Cardiol; 2016 Jun; 105(6):527-34. PubMed ID: 26687495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients.
    Reil JC; Tardif JC; Ford I; Lloyd SM; O'Meara E; Komajda M; Borer JS; Tavazzi L; Swedberg K; Böhm M
    J Am Coll Cardiol; 2013 Nov; 62(21):1977-1985. PubMed ID: 23933545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of ivabradine versus beta-blockers in patients with mitral stenosis in sinus rhythm: systematic review and meta-analysis.
    Ghadimi N; Kaveh S; Shabaninejad H; Lijassi A; Mehr AZ; Hosseinifard H
    Int J Clin Pharm; 2019 Feb; 41(1):22-29. PubMed ID: 30659493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.